SCHEMBL9986859

SCHEMBL9986859

CON(C)C(=O)c1[nH]c2ccccc2c1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.58
▸ HSD17B10 Q99714 2/20 0.58
▸ MAPT P10636 2/20 0.51
▸ HPGD P15428 2/20 0.51
▸ USP2 O75604 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ MAOA P21397 1/20 0.45
▸ NR4A2 P43354 1/20 0.44
▸ HPGDS O60760 2/20 0.44
▸ HTR1A P08908 1/20 0.44
▸ DRD2 P14416 1/20 0.44
▸ DRD4 P21917 1/20 0.44
▸ HTR1D P28221 1/20 0.44
▸ HTR1B P28222 1/20 0.44
▸ HTR1F P30939 1/20 0.44
▸ HTR7 P34969 1/20 0.44
▸ DRD3 P35462 1/20 0.44
▸ HTR6 P50406 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8938374 0.78 TUBB4A (0.68) MAPTMEN1KMT2ATUBB4ATUBB
SCHEMBL14419949 0.78 KDM4E (0.46) ALDH1A1HSD17B10MAPTHPGDMEN1
SCHEMBL29736213 0.78 ALDH1A1 (0.65) ALDH1A1HSD17B10MAPTHPGDUSP2
SCHEMBL5508274 0.78 ALDH1A1 (0.65) ALDH1A1HSD17B10MAPTHPGDUSP2
SCHEMBL21331151 0.77 ALDH1A1 (0.56) ALDH1A1HSD17B10MAPTHPGDUSP2
SCHEMBL29897041 0.77 ALDH1A1 (0.63) ALDH1A1HSD17B10MAPTHPGDUSP2
SCHEMBL2399274 0.77 ALDH1A1 (0.63) ALDH1A1HSD17B10MAPTHPGDUSP2
SCHEMBL2722021 0.77 ALDH1A1 (0.63) ALDH1A1HSD17B10MAPTHPGDUSP2
SCHEMBL10704376 0.75 ALDH1A1 (0.61) ALDH1A1HSD17B10MAPTHPGDUSP2
SCHEMBL5480808 0.74 KDM4E (0.40) ALDH1A1HSD17B10MAPTHPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9062055-B2 Fused pyrrole derivatives as PI3K inhibitors INCYTE CORPORATION (US) 2015-06-23 — — US disclosed
US-9062055-B2 Fused pyrrole derivatives as PI3K inhibitors INCYTE CORPORATION (US) 2015-06-23 — — US disclosed
WO-2011163195-A1 FUSED PYRROLE DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-12-29 — — WO disclosed
US-20110312979-A1 FUSED PYRROLE DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION 2011-12-22 — — US disclosed
US-20110312979-A1 FUSED PYRROLE DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION 2011-12-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312979-A1 FUSED PYRROLE DERIVATIVES AS PI3K INHIBITORS PIK3R5, PIK3R4, PIK3CA ALDH1A1 3993/4885HSD17B10 2900/4885MAPT 4256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback